Bayer has announced that the HSE has granted hospital pricing approval for EYLEA® 8mg for eligible adult patients with wet age-related macular degeneration and diabetic macular oedema in Ireland.
Read more
RCSI has launched Ireland’s first National Robotic Surgery Curriculum, supported by a €2.3m investment and designed to standardise robotic surgical training nationwide.
Read more
RCSI has launched Ireland’s first National Robotic Surgery Curriculum, supported by a €2.3m investment and designed to standardise robotic surgical training nationwide.
Read more
Nordic Pharma has announced the European launch of Lacrifill®, a CE-marked canalicular gel designed to enhance tear film preservation in patients with dry eye disease.
Read more
Introduction Refractive surgery encompasses a range of procedures designed to correct or minimize refractive errors such as myopia (nearsightedness), hyperopia
Read more
Glaucoma is the most common cause of irreversible blindness worldwide. Open-angle glaucoma (OAG) is the most frequent phenotype, with a
Read more
Age related macular degeneration (AMD) is the leading cause of sight loss in the over 50s in Ireland. More than
Read more
Macular oedema is the end common pathway for many prevalent ophthalmic conditions. It is one of the leading causes of
Read more
[pdf-embedder url=”https://hospitalprofessionalnews.ie/wp-content/uploads/2021/10/Increasing-the-Visibility-of-Women-An-initiative-by-the-Women-in-Vision-and-Eye-Research-Ireland.pdf” title=”Increasing the Visibility of Women – An initiative by the Women in Vision and Eye Research Ireland”]
Read more
[pdf-embedder url=”https://hospitalprofessionalnews.ie/wp-content/uploads/2020/11/Potential-new-treatment-for-severe-dry-eye-disease-RCSI.pdf” title=”Potential new treatment for severe dry eye disease, RCSI”]
Read more